deltatrials
Recruiting OBSERVATIONAL NCT02917369

Integrative Analysis of Large-cell Lung Cancer (LCLC)

Integrative Analysis of Large-cell Lung Carcinoma

Sponsor: Shanghai 10th People's Hospital

Conditions Lung Cancer
Interventions Normal lung tissue
Updated 5 times since 2017 Last updated: Sep 27, 2016 Started: Jan 31, 2016 Primary completion: Dec 31, 2026 Completion: Dec 31, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Lung Cancer, this trial is actively recruiting participants. The trial is conducted by Shanghai 10th People's Hospital and has accumulated 5 data snapshots since 2016. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Jan 2017 – ~Apr 2018 · 15 months · monthly snapshotRecruiting~Apr 2018 – ~Jan 2021 · 33 months · monthly snapshotRecruiting~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotRecruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotRecruiting~Sep 2024 – present · 21 months · monthly snapshotRecruiting

Change History

5 versions recorded
  1. Sep 2024 — Present [monthly]

    Recruiting

  2. Jul 2024 — Sep 2024 [monthly]

    Recruiting

  3. Jan 2021 — Jul 2024 [monthly]

    Recruiting

  4. Apr 2018 — Jan 2021 [monthly]

    Recruiting

    Phase: NANone

  5. Jan 2017 — Apr 2018 [monthly]

    Recruiting NA

    First recorded

Jan 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Shanghai 10th People's Hospital
  • Shanghai Pulmonary Hospital, Shanghai, China
Data source: Shanghai 10th People's Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations